The babraham accelerator was the very beginning of our journey. We rocked up with absolutely nothing, except a stellar idea on how to get more antibodies into tumours. It was the accelerator that got us off the blocks. If you are looking to start your venture, get off to the right start.. applications open in the new year #startup Babraham Research Campus #entrepreneur ##curecancer #womeninstem
Accelerate@Babraham alumni CREASALLIS was part of the 2021/22 cohort and is now a fully-fledged Campus tenant. The pioneering antibody solutions company led by Zahra Jawad, is at the forefront of developing novel protein engineering solutions for antibody-based therapeutics. As part of our bio-incubator programme Creasallis found itself in an environment that provided more than just lab space - it offered the critical infrastructure, collaborative community, and unparalleled support that a young start-up needs to flourish For Creasallis, the combination of cutting-edge facilities, a rich network of expertise, and an environment that supports both innovation and operational efficiency has allowed the company to progress its vision to deliver safer, more effective antibody-based therapies to patients. Find out more about their journey in the case study in our Babraham Research Campus Impact report summary (p8) – https://ow.ly/z4wK50Uo92w And if you're interested in being part of the next cohort of Accelerate@Babraham applications will open on Jan 13 2025!